Title: Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps
Authors: Bousquet, Jean ×
Bachert, Claus
Bernstein, Jonathan
Canonica, G Walter
Carr, Warner
Dahl, Ronald
Demoly, Pascal
Devillier, Philippe
Hellings, Peter
Fokkens, Wytske
Klimek, Ludger
Lieberman, Phil
Meltzer, Eli
Price, David
Ryan, Dermot
Wahn, Ulrich #
Issue Date: Apr-2015
Publisher: Ashley Publications
Series Title: Expert Opinion on Pharmacotherapy vol:16 issue:6 pages:913-28
Article number: 10.1517/14656566.2015.1020789
Abstract: Effective pharmacologic treatment exists for most patients suffering from allergic rhinitis (AR). However, both in clinical trials and in real-life studies, many patients are dissatisfied with treatment. Physicians often use multiple therapies, in an attempt to improve symptom control, often with limited evidence of success. Novel treatment options are needed and must consider unmet medical needs.
ISSN: 1465-6566
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Laboratory of Clinical Immunology
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science